ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,470.80
      -0.38%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Incyte Corporation (INCY)

      7. Incyte Corporation (INCY) News

      INCY

      Incyte (INCY)

      Incyte Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INCY
      DateTimeSourceHeadlineSymbolCompany
      12/12/20118:30AMBusiness WireFirst FDA-Approved Treatment for Myelofibrosis, Jakafi™ (ruxolitinib), Discussed in Multiple Presentations at 2011 ASH Annu...NASDAQ:INCYIncyte Corporation
      12/07/20115:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      12/01/20114:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/30/20114:10PMBusiness WireIncyte to Present at the Oppenheimer & Co. 22nd Annual Healthcare ConferenceNASDAQ:INCYIncyte Corporation
      11/30/20119:58AMDow Jones NewsApplications Given Early Antitrust ClearanceNASDAQ:INCYIncyte Corporation
      11/21/20114:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20118:00AMBusiness WireIncyte to Present at the 23rd Annual Piper Jaffray Health Care ConferenceNASDAQ:INCYIncyte Corporation
      11/17/20116:45AMZacksIncyte Drug Cleared in the US - Analyst BlogNASDAQ:INCYIncyte Corporation
      11/16/20114:42PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
      11/16/201111:18AMBusiness WireFDA Approves Incyte’s Jakafi™ (ruxolitinib) for Patients with MyelofibrosisNASDAQ:INCYIncyte Corporation
      11/02/201112:12PMZacksLoss Widens at Incyte - Analyst BlogNASDAQ:INCYIncyte Corporation
      10/27/20114:27PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:INCYIncyte Corporation
      10/27/20117:44AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
      10/27/20117:00AMBusiness WireIncyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
      10/13/20114:15PMBusiness WireIncyte to Report Third Quarter 2011 Financial Results and Provide Update on Key Clinical Programs on October 27NASDAQ:INCYIncyte Corporation
      10/11/201112:34PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:INCYIncyte Corporation
      08/30/20114:15PMBusiness WireIncyte to Present at Upcoming Investor ConferencesNASDAQ:INCYIncyte Corporation
      08/30/201110:15AMZacksNeutral View on Incyte - Analyst BlogNASDAQ:INCYIncyte Corporation
      08/15/20114:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      08/10/20114:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      08/10/20114:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INCYIncyte Corporation
      08/03/20117:00AMBusiness WireFDA Accepts NDA Filing for Ruxolitinib as a Treatment for MyelofibrosisNASDAQ:INCYIncyte Corporation
      08/02/20119:30AMPR Newswire (US)The Zacks Analyst Blog Highlights: Archer Daniels Midland Company, Incyte Corporation, Eli Lilly and Company, Pfizer and Nova...NASDAQ:INCYIncyte Corporation
      08/01/201112:26PMZacksIncyte Does Not Excite - Analyst BlogNASDAQ:INCYIncyte Corporation
      07/28/20114:14PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:INCYIncyte Corporation
      07/28/20117:23AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
      07/28/20117:00AMBusiness WireIncyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
      07/19/201111:00AMZacksNovartis Beats Soundly - Analyst BlogNASDAQ:INCYIncyte Corporation
      07/19/201111:00AMZacksNovartis Beats Soundly - Analyst BlogNASDAQ:INCYIncyte Corporation
      07/13/20114:15PMBusiness WireIncyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical Programs on July 28NASDAQ:INCYIncyte Corporation
       Showing the most relevant articles for your search:NASDAQ:INCY